Salta al contenuto principale
Passa alla visualizzazione normale.

CIRO CELSA

Pubblicazioni

Data Titolo Tipologia Scheda
2024 Initial uptake of durvalumab with or without tremelimumab for advanced hepatocellular carcinoma in routine clinical practice: Preliminary results of the international DT-real study Abstract in atti di convegno pubblicato in rivista Vai
2024 Navigating the landscape of liver cancer management: Study designs in clinical trials and clinical practice Review essay (rassegna critica) Vai
2024 Reply to: “irLI or not irLI: That is the question” Lettera Vai
2024 Clinical outcomes of MAFLD versus NAFLD: A meta-analysis of observational studies Articolo in rivista Vai
2024 Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours Articolo in rivista Vai
2024 Hepatic decompensation is the major driver of mortality in patients with HCC treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment Articolo in rivista Vai
2024 Impact of metformin, statin, aspirin and insulin on the prognosis of uHCC patients receiving first line Lenvatinib or Atezolizumab plus Bevacizumab Articolo in rivista Vai
2024 What is the benefit of prophylaxis to prevent HBV reactivation in HBsAg-negative anti-HBc-positive patients? Meta-analysis and decision curve analysis Articolo in rivista Vai
2023 Balancing Efficacy and Tolerability of First-Line Systemic Therapies for Advanced Hepatocellular Carcinoma: A Network Meta-Analysis Articolo in rivista Vai
2023 Hepatic encephalopathy increases the risk for mortality and hospital readmission in decompensated cirrhotic patients: a prospective multicenter study Articolo in rivista Vai
2023 Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs Articolo in rivista Vai
2023 Evaluating the risk-benefit ratio of immunotherapy according to liver-functional reserve in advanced HCC: the dark side of the moon Nota o commento Vai
2023 Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept Review essay (rassegna critica) Vai
2023 The price and value of therapeutic synergy in liver cancer Nota o commento Vai
2023 Reply Lettera Vai
2023 Expert opinion vs. meta-analysis: To be or not to be? Lettera Vai
2023 Mechanisms of Resistance to Immunotherapy in Hepatocellular Carcinoma Articolo in rivista Vai
2023 Textbook Outcome After Trans-arterial Chemoembolization for Hepatocellular Carcinoma Articolo in rivista Vai
2022 Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma: A Real-life Multicentric Weighted Comparison Articolo in rivista Vai
2022 COSMIC-312: mounting immunotherapy enigmas for hepatocellular carcinoma Lettera Vai
2022 Reply Lettera Vai
2022 The Evolving Scenario in the Assessment of Radiological Response for Hepatocellular Carcinoma in the Era of Immunotherapy: Strengths and Weaknesses of Surrogate Endpoints Articolo in rivista Vai
2022 Radiomics Analysis on Gadoxetate Disodium-Enhanced MRI Predicts Response to Transarterial Embolization in Patients with HCC Articolo in rivista Vai
2022 Endothelial angiopoietin-2 overexpression in explanted livers identifies subjects at higher risk of recurrence of hepatocellular carcinoma after liver transplantation Articolo in rivista Vai
2022 Role of LI-RADS Indeterminate Observations in the Risk of Hepatocellular Carcinoma after HCV Eradication with Direct-Acting Antivirals Articolo in rivista Vai
2022 Validation of the easy-to-use lenvatinib prognostic index to predict prognosis in advanced hepatocellular carcinoma patients treated with lenvatinib Articolo in rivista Vai
2022 AGILE 3+ Score for the Diagnosis of Advanced Fibrosis and for Predicting Liver-related Events in NAFLD Articolo in rivista Vai
2022 Telemedicine Is an Effective Tool to Monitor Disease Activity in IBD Patients in the COVID-19 Era: A Single Centre Experience Based on Objective Data Articolo in rivista Vai
2022 Reliability of grading preoperative pancreatic neuroendocrine tumors on EUS specimens: a systematic review with meta-analysis of aggregate and individual data Articolo in rivista Vai
2022 Mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis: A validated prediction model Articolo in rivista Vai
2022 RESIST-HCV Criteria to Monitor Progression of Low-Risk Esophageal Varices in Patients With Compensated Cirrhosis After HCV Eradication: The SIMPLE Study: SIMPLE: Scoring Index to Monitor Progression of Low-risk Esophageal varices Articolo in rivista Vai
2022 Effect of pharmacological interventions and placebo on liver Histology in nonalcoholic steatohepatitis: A network meta-analysis Articolo in rivista Vai
2022 Transarterial Chemoembolization for Hepatocellular Carcinoma in Clinical Practice: Temporal Trends and Survival Outcomes of an Iterative Treatment Articolo in rivista Vai
2022 Direct-acting antiviral agents and risk of Hepatocellular carcinoma: Critical appraisal of the evidence Articolo in rivista Vai
2021 Impact of biliary stents on the diagnostic accuracy of EUS-guided fine-needle biopsy of solid pancreatic head lesions: A multicenter study Articolo in rivista Vai
2021 Competing-risk analysis of coronavirus disease 2019 in-hospital mortality in a Northern Italian centre from SMAtteo COvid19 REgistry (SMACORE) Articolo in rivista Vai
2021 Are radiological endpoints surrogate outcomes of overall survival in hepatocellular carcinoma treated with transarterial chemoembolization? Articolo in rivista Vai
2021 Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: An individual patient data meta-analysis Articolo in rivista Vai
2021 First-Line Immune Checkpoint Inhibitor-Based Sequential Therapies for Advanced Hepatocellular Carcinoma: Rationale for Future Trials Articolo in rivista Vai
2021 Identification of clinical phenotypes and related survival in patients with large hccs Articolo in rivista Vai
2021 Consequences of Extended Spectrum Beta-Lactamase–Producing Enterobacteriaceae and Methicillin-Resistant Staphylococcus aureus Carriage in Awaiting Liver Transplant Patients Articolo in rivista Vai
2021 Biliary complications after liver transplantation: current perspectives and future strategies Review essay (rassegna critica) Vai
2021 Systemic therapies for hepatocellular carcinoma: The present and the future Articolo in rivista Vai
2021 Long-term evolution of LI-RADS observations in HCV-related cirrhosis treated with direct-acting antivirals Articolo in rivista Vai
2021 Dynamic angiopoietin-2 assessment predicts survival and chronic course in hospitalized patients with COVID-19 Articolo in rivista Vai
2021 Surveillance as determinant of long-term survival in non-transplanted hepatocellular carcinoma patients Articolo in rivista Vai
2021 Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter study Articolo in rivista Vai
2021 Real-Life Clinical Data of Lenvatinib versus Sorafenib for Unresectable Hepatocellular Carcinoma in Italy Articolo in rivista Vai
2021 Predicting in-hospital mortality from Coronavirus Disease 2019: A simple validated app for clinical use Articolo in rivista Vai
2021 Progression-Free Survival Early Assessment Is a Robust Surrogate Endpoint of Overall Survival in Immunotherapy Trials of Hepatocellular Carcinoma Articolo in rivista Vai
2020 Sicily Network for Liver Cancer: A Multidisciplinary Network Model for the Management of Primary Liver Tumors Articolo in rivista Vai
2020 Optimizing sequential systemic therapies for advanced hepatocellular carcinoma: A decision analysis Articolo in rivista Vai
2020 Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients with Non-alcoholic Fatty Liver Disease Articolo in rivista Vai
2020 Utility of neutrophil-to-lymphocyte ratio to identify long-term survivors among HCC patients treated with sorafenib Articolo in rivista Vai
2020 The role of PNI to predict survival in advanced hepatocellular carcinoma treated with Sorafenib Articolo in rivista Vai
2020 Diagnostic performance of endoscopic ultrasound through-the-needle microforceps biopsy of pancreatic cystic lesions: Systematic review with meta-analysis Articolo in rivista Vai
2020 The relevance of noninvasive tools to assess fibrosis in non-alcoholic fatty liver disease Articolo in rivista Vai
2020 Biochemical biomarkers of NAFLD/NASH Capitolo o Saggio Vai
2020 Efficacy of lumen-apposing metal stents or self-expandable metal stents for endoscopic ultrasound-guided choledochoduodenostomy: A systematic review and meta-analysis Articolo in rivista Vai
2020 Through-the-needle biopsy of pancreatic cystic lesions: stronger evidences of higher diagnostic yield compared with cytology Articolo in rivista Vai
2019 Pharmacological therapy of non-alcoholic fatty liver disease: What drugs are available now and future perspectives Articolo in rivista Vai
2019 Risk Factors for Rate of Relapse and Effects of Steroid Maintenance Therapy in Patients With Autoimmune Pancreatitis: Systematic Review and Meta-analysis Articolo in rivista Vai
2019 The burden of hepatocellular carcinoma in non-alcoholic fatty liver disease: Screening issue and future perspectives Articolo in rivista Vai
2019 Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients Articolo in rivista Vai
2019 Direct acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients Abstract in atti di convegno pubblicato in rivista Vai
2019 Outcomes of hepatocellular carcinoma patients treated with sorafenib: A meta-analysis of Phase III trials Articolo in rivista Vai
2018 Should we cure hepatitis C virus in patients with hepatocellular carcinoma while treating cancer? Articolo in rivista Vai
2018 Antidiabetic drugs in NAFLD: The accomplishment of two goals at once? Articolo in rivista Vai
2018 Direct-acting antiviral agents and risk of hepatocellular carcinoma: is it still a clinical dilemma? Articolo in rivista Vai